Texaphyrin complexes having improved functionalization
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61B-005/055
C07D-257/00
A61K-049/00
출원번호
US-0468209
(1995-06-06)
발명자
/ 주소
Hemmi Gregory W. (Sunnyvale CA) Sessler Jonathan L. (Austin TX) Mody Tarak D. (Sunnyvale CA)
출원인 / 주소
Pharmacyclics, Inc. (Sunnyvale CA 02) Board of Regents, The University of Texas System (Austin TX 02)
인용정보
피인용 횟수 :
29인용 특허 :
32
초록▼
Texaphyrin metal complexes having improved functionalization include the addition of electron-donating groups to positions 2, 7, 12, 15, 18 and/or 21 and/or the addition of electron-withdrawing groups to positions 15 and/or 18 of the macrocycle. Electron-donating groups at positions 2, 7, 12, 15, 18
Texaphyrin metal complexes having improved functionalization include the addition of electron-donating groups to positions 2, 7, 12, 15, 18 and/or 21 and/or the addition of electron-withdrawing groups to positions 15 and/or 18 of the macrocycle. Electron-donating groups at positions 2, 7, 12, 15, 18 and/or 21 contribute electrons to the aromatic p
대표청구항▼
A method of radiation therapy for a host harboring atheroma or neoplastic tissue, the method comprising: administering to the host a texaphyrin, the texaphyrin having radiosensitization properties; and administering ionizing radiation to the host in proximity to the atheroma or neoplastic tissue; wh
A method of radiation therapy for a host harboring atheroma or neoplastic tissue, the method comprising: administering to the host a texaphyrin, the texaphyrin having radiosensitization properties; and administering ionizing radiation to the host in proximity to the atheroma or neoplastic tissue; wherein the texaphyrin has the structure: [Figure] wherein M is H, a divalent metal cation, or a trivalent metal cation; R1-R4, R7 and R8 are independently hydrogen, halide, hydroxyl, alkyl, aryl, haloalkyl, nitro, formyl, acyl, hydroxyalkyl, oxyalkyl, oxyhydroxyalkyl, saccharide, carboxy, carboxyalkyl, carboxyamidealkyl, a site-directing molecule, a catalytic group, or a couple to a site-directing molecule or to a catalytic group; R6 and R9 are independently selected from the groups of R1-R4, R7 and R8, with the proviso that the halide is other than iodide and the haloalkyl is other than iodoalkyl; R5and R10-R12 are independently hydrogen, alkyl, aryl, hydroxyalkyl, oxyalkyl, oxyhydroxyalkyl, carboxyalkyl, carboxyamidealkyl or a couple to a saccharide, to a site-directing molecule or to a catalytic group; at least one of R5, R6, R9, R10, R11 and R12 is other than hydrogen; and Z is an integer less than or equal to 5.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (32)
Parker David (Durham GBX) Millican Thomas A. (Maidenhead GBX), Antibody conjugates with macrocyclic ligands.
Sessler Jonathan L. (Austin TX) Hemmi Gregory W. (Austin TX) Murai Toshiaki (Gifu JPX), Aromatic pentadentate expanded porphyrins in magnetic resonance imaging.
Sessler Jonathan L. (Austin TX) Hemmi Gregory W. (Austin TX) Murai Toshiaki (Gifu JPX), Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles.
Sessler Jonathan L. (Austin TX) Hemmi Gregory W. (Austin TX) Murai Toshiaki (Nagara JPX), Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles.
Sessler Jonathan L. (Austin TX) Hemmi Gregory W. (Austin TX) Murai Toshiaki (Gifu JPX), Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles and methods for treating tumors.
Sessler Jonathan L. (Austin TX) Toshiaki Murai (Gifu TX JPX) Hemmi Gregory W. (Austin TX), Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles for singlet oxygen production.
Judy Millard M. (Dallas TX) Matthews James L. (Dallas TX) Newman Joseph T. (Dallas TX) Sogandares-Bernal Franklin (Dallas TX), Method for eradicating infectious biological contaminants in body tissues.
Judy Millard M. (Dallas TX) Matthews James L. (Dallas TX) Newman Joseph T. (Dallas TX) Sogandares-Bernal Franklin (Dallas TX), Method for eradicating infectious biological contaminants in body tissues.
Cole Dean A. (Germantown MD) Moody ; III David C. (Superior CO) Ellinwood L. Edward (Grand Junction CO) Klein M. Gerard (Grand Junction CO), Method using 5,10,15,20-tetrakis(4-carboxyphenyl)porphine for treating cancers of the lung.
Burrows Cynthia J. (Stony Brook NY) Rokita Steven E. (Port Jefferson NY) Chen Xiaoying (Stony Brook NY), Modification of DNA and oligonucleotides using metal complexes of polyaza ligands.
Nguyen Thanh T. (Tigy FRX) Helene Claude (Saint Cyr en Val FRX) Asseline Ulysse (La Source FRX), Novel compounds containing an oligonucleotide sequence bonded to an intercalating agent, a process for their synthesis a.
Matthews J. Lester (Dallas TX) Judy Millard M. (Dallas TX) Newman Joseph T. (Dallas TX) Sogandares-Bernal Frank (Dallas TX) Sessler Jonathan L. (Austin TX) Harriman Anthony (Austin TX) Maiya Bhaskar , Photodynamic viral deactivation with sapphyrins.
Sessler Jonathan L. (Austin TX) Hemmi Gregory W. (Austin TX) Murai Toshiaki (Gifu JPX), Process for preparing expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles.
Morgan Alan R. (Swanton OH) Selman Steven H. (Toledo OH) Kreimer-Birnbaum Martha (Toledo OH), Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions.
Morgan Alan R. (Toledo OH) Selman Steven H. (Toledo OH) Kreimer-Birnbaum Martha (Toledo OH), Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions.
Therien Michael J. (Philadelphia PA) DiMagno Stephen G. (Philadelphia PA), Substituted porphyrins, porphyrin-containing polymers, and synthetic methods therefor.
Cohen Jack S. (Bethesda MD) Chen Chi-Wan (Silver Spring MD) Myers Charles E. (Rockville MD) Sohn Miriam (Washington DC 4), Use of paramagnetic metalloporphyrins as contrast agents for tumors in MRI imaging.
Sessler Jonathan L. (Austin TX) Hemmi Gregory W. (Austin TX) Mody Tarak D. (Austin TX), Water soluble texaphyrin metal complexes for singlet oxygen production.
Sessler Jonathan L. (Austin TX) Hemmi Gregory W. (Austin TX) Mody Tarak D. (Austin TX), Water soluble texaphyrin metal complexes for viral deactivation.
Dees, H. Craig; Scott, Timothy C.; Wachter, Eric A.; Fisher, Walter G.; Smolik, John, Intracorporeal medicaments for high energy phototherapeutic treatment of disease.
Dees, H. Craig; Scott, Timothy C.; Wachter, Eric A.; Fisher, Walter G.; Smolik, John, Intracorporeal medicaments for photodynamic treatment of disease.
Adair,Edwin L., Method of cancer screening primarily utilizing non-invasive cell collection, fluorescence detection techniques, and radio tracing detection techniques.
Sessler Jonathan L. ; Harriman Anthony,FRX ; Miller Richard A. ; Magda Darren ; Mody Tarak D. ; Hemmi Gregory W., Radiation sensitization using texaphyrins.
Dees, H. Craig; Scott, Timothy C.; Smolik, John; Wachter, Eric A.; Fisher, Walter G., Topical medicaments and methods for photodynamic treatment of disease.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.